20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Neuroprotective Potential of Mildronate: Insights for Brain Health

Beyond its established role in cardiovascular health, Mildronate (CAS 76144-81-5) exhibits promising neuroprotective properties. These effects are crucial for understanding its potential in treating various neurological disorders and supporting overall brain function. NINGBO INNO PHARMCHEM CO., LTD is at the forefront of supplying high-quality pharmaceutical intermediates that contribute to advancements in neurological research and treatment.

Research indicates that Mildronate can positively influence cerebral circulation disorders. By optimizing energy metabolism within brain cells and protecting them from damage caused by insufficient blood flow or oxygen, it contributes to improved cognitive function and recovery from neurological insults. The compound's ability to regulate cellular energy pathways is key to these neuroprotective effects. Its role in improving how to inhibit carnitine biosynthesis is fundamental to its action in the brain.

Mildronate has been observed to improve central nervous system functions, potentially alleviating symptoms associated with brain injury, stroke, and even chronic alcoholism withdrawal. In patients suffering from cerebrovascular diseases, Mildronate may aid in restoring normal brain activity and reducing the severity of symptoms. This application underscores its value as a pharmaceutical compound for complex neurological conditions.

The precise mechanisms by which Mildronate exerts its neuroprotective effects are still under investigation, but its impact on cellular energy metabolism and its anti-ischemic properties are considered primary factors. As a trusted supplier, NINGBO INNO PHARMCHEM CO., LTD is committed to providing researchers and pharmaceutical manufacturers with reliable access to Mildronate, facilitating further exploration into its therapeutic potential. The ongoing study into how to inhibit carnitine biosynthesis continues to reveal new avenues for its application in brain health.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Mildronate and Cardiovascular Health: A Comprehensive Look at its Protective Role

Next: Mildronate in Sports: Performance Enhancement and Regulatory Status

All Rights Reserved